Forthcoming Special Issues

17 August 2022

Cancer vaccine development

In a small number of individual clinical cases, cancer vaccines appear to achieve remarkable results. There have been significant advances in the field of cancer vaccines with many treatments in clinical trials or with promising pre-clinical results. Here we feature a number of original research papers and reviews in this field that represent the cutting edge of knowledge and practice, and address the challenges and drawbacks of specific approaches.

Guest editors:

Alan G Raetz, Antigen Research.

Manuscript submission information:

Submission deadlineFebruary 1, 2023.

You are invited to submit your manuscript at any time before the submission deadline. For any inquiries about the appropriateness of contribution topics, please contact Dr. Alan Raetz via [email protected]

The journal’s submission platform (Editorial Manager®) is now available for receiving submissions to this Special Issue. Please refer to the Guide for Authors to prepare your manuscript, and select the article type of “Cancer vaccine development” when submitting your manuscript online. Both the Guide for Authors and the submission portal could be found on the Journal Homepage here: 

All the submissions deemed suitable to be sent for peer review will be reviewed by at least two independent reviewers. Upon its editorial acceptance, your article will go into production immediately. It will be published in the latest regular issue, while be presented on the specific Special Issue webpage simultaneously. In regular issues, Special Issue articles will be clearly marked and branded.


(Cancer vaccine) OR (vaccine vaccines) OR (cancer neoantigen vaccines).

Learn more about the benefits of publishing in a special issue:

Interested in becoming a guest editor? Discover the benefits of guest editing a special issue and the valuable contribution that you can make to your field: